Promising diabetes drug

It was a spectacular day for shareholders of another drug maker, MannKind. Shares surged an astounding 74 percent after an FDA panel recommended the approval of its experimental diabetes drug which you inhale, which means more needles to get insulin. Sheila Dharmarajan has more on the hopes for this new drug and what it will take before it hits the market.

This entry was posted in Biotech & Pharmaceuticals, Health Care, NBR Show Clips. Bookmark the permalink.

Leave a Reply